Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
about
Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeastHow drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionTowards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesIndividuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyFitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can FlyEvent-based text mining for biology and functional genomicsRational approaches to improving selectivity in drug designMathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survivalMetabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryStructural analysis of a peptide fragment of transmembrane transporter protein bilitranslocasepH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive DiffusionMapping the genome of Plasmodium falciparum on the drug-like chemical space reveals novel anti-malarial targets and potential drug leadsFosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathwaysA Dormant Microbial Component in the Development of PreeclampsiaThe metabolome 18 years on: a concept comes of ageEfficient discovery of anti-inflammatory small-molecule combinations using evolutionary computingRational methods for the selection of diverse screening compoundsIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesWhat can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?Codelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorNanomicellar Formulation of Clotrimazole Improves Its Antitumor Action toward Human Breast Cancer CellsMetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous MetabolitesBreeding crop plants with deep roots: their role in sustainable carbon, nutrient and water sequestrationMembrane transporters as mediators of Cisplatin effects and side effects.Label-Free Raman Microspectral Analysis for Comparison of Cellular Uptake and Distribution between Non-Targeted and EGFR-Targeted Biodegradable Polymeric NanoparticlesCationic sulfonium functionalization renders Znsalens with high fluorescence, good water solubility and tunable cell-permeability.Intracellular distribution of nontargeted quantum dots after natural uptake and microinjection.Bisphosphonate inhibition of a Plasmodium farnesyl diphosphate synthase and a general method for predicting cell-based activity from enzyme dataExpanding the range of 'druggable' targets with natural product-based libraries: an academic perspective.Malaria parasite mutants with altered erythrocyte permeability: a new drug resistance mechanism and important molecular tool.Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins.Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.Contaminants of emerging concern in a large temperate estuaryA method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulationsDissecting variability in responses to cancer chemotherapy through systems pharmacology.Nuclear export mediated regulation of microRNAs: potential target for drug intervention.Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats.Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.Predictive approaches to increase absorption of compounds during lead optimisation.
P2860
Q21245306-EF55311B-B438-4CEE-B761-EB915A29F0C1Q24273350-DE64853D-E0DD-4C33-AF48-7A2DD62AF117Q24289511-A8AC9C1A-63AD-4D6F-A995-016410A70777Q26775404-12540103-9DE7-4837-928F-38F511A358E4Q26780025-A0C58814-1677-4259-B74C-03049C8C6C65Q26823739-4EAA16A5-32C4-4912-B06C-ACADF2471785Q26865357-85CACB0E-911D-41F1-8158-E625888799E2Q27023583-DBC45FB6-2831-4F43-802C-DA750A587780Q27144251-C31170BC-1B6B-40BC-9231-29B199868128Q27301091-77224A26-07B1-4F37-8587-684349047B11Q27314887-85120BBE-0C5E-447B-AB7C-A13EF458C961Q27972942-B6F9E2EA-1AFA-4659-8C67-260C14CDAE1AQ27974683-B7438529-F89B-4925-9B34-63BAD23C0E21Q28069689-8D91D7C4-24F8-4A6F-A146-EC05E523AA95Q28080314-691F96BE-8C26-4F84-A5F2-0E7BDFF92B57Q28251171-3DD4C6EB-2900-478D-B0F8-C16D8A4F4CBCQ28303907-BE507EFD-7DD1-49F8-87FD-46212CA713F9Q28388335-372769FB-7059-4334-A239-5243BB8C0413Q28484296-A8BE0A25-0B92-43F1-A46F-61D3CC37326CQ28543911-4D2D2496-F062-4B48-BA8C-C71389403899Q28548517-6304269E-E7E1-4238-8A6B-1B221FAB2576Q28597594-5F244AD1-24DC-4A89-9B5A-C5BF66A64F83Q28741243-0126AFB0-9DA4-4E4D-A660-37E08556D1CEQ30446860-FF619B8C-12BB-45E5-8FAA-49E73520741AQ30558038-069C33E0-270F-423E-B3AA-F4D6D2964C22Q31046482-2A362884-3CD1-4B10-A7CA-07534BDE87A0Q31111393-D9FB8950-55E5-4EEC-8A62-6805DFDD701AQ33389309-D4694C9C-E2B6-48D3-8A3D-A09A7B0BF72DQ33536938-F89C83A5-6962-42DC-A0C3-3F9431571DFCQ33641507-84DB1C5F-12B2-4157-8286-B0EECC0AAB3DQ33718901-CF7E4A04-BC22-41D6-9DF7-30571C74F2A4Q33763765-343A02CC-C0D1-496F-84DC-A9F959F0684CQ33834662-C4398FBE-E3DA-4FDB-97F4-F38F1D05BDD1Q33902531-83B4D933-D043-49C2-BD0E-6C2F86A8EE07Q34031018-37456089-B1FD-41B0-8825-F264F1396366Q34139962-622992D7-84F1-45F4-8DFB-F5C9F37E35B7Q34204130-F626D484-63F5-4DE1-9E3E-04AD893FC809Q34483537-8B144469-54A3-4926-9B95-2C0E587DDDF1Q34646772-11E4B079-93D9-41BD-8C06-A2BE98E01060Q34833273-BBEDD82D-2426-45F9-B7CC-75BD9393A12D
P2860
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
@en
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
@nl
type
label
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
@en
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
@nl
prefLabel
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
@en
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
@nl
P356
P1476
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
@en
P2093
Paul D Dobson
P2888
P304
P356
10.1038/NRD2438
P50
P577
2008-03-01T00:00:00Z
P5875
P6179
1045987740